跳至主要内容
临床试验/DRKS00024015
DRKS00024015已完成未知

PRO B - patient-reported outcomes in breast diseases - New approaches in the care of metastatic breast cancer - PRO B

Charité - Universitätsmedizin Berlin0 个研究点目标入组 924 人开始时间: 2021年2月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
924

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • - with metastatic breast cancer,
  • - who are treated in a participating breast cancer center,
  • - who are insured with one of the following health insurance companies: BARMER, DAK Gesundheit, BKK-VBU*,
  • - who are able to consent,
  • - who are older than 18,
  • - who are receiving drug treatment for metastatic breast cancer,
  • - who have a life expectancy of more than 3 months at enrollment,
  • - who are classified as ECOG 0-2,
  • - who are willing to participate in a weekly, online-based PRO survey,
  • - and who have access to the internet (smartphone, tablet)
  • may be included.
  • *after extension of the legal basis, participation is temporarily possible for patients of other health insurance companies

排除标准

  • Patients who do not receive active cancer therapy (comfort care) or who do not meet all of the inclusion criteria are not eligible to participate.

研究者

相似试验